K. Doleckova

Huntingtin Co-Isolates with Small Extracellular Vesicles from Blood Plasma of TgHD and KI-HD Pig Models of Huntington’s Disease and Human Blood Plasma

J. Klempír, P. Vodička, J. Juhasova, 2022, International journal of molecular sciences.

Predictive factors for a severe course of COVID‐19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival

J. Bednařík, Magda Horáková, S. Voháňka, 2021, European journal of neurology.

Predictive factors for a severe course of COVID‐19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival

J. Bednařík, Magda Horáková, S. Voháňka, 2021, European journal of neurology.

SPG11: clinical and genetic features of seven Czech patients and literature review

R. Jech, J. Roth, P. Seeman, 2022, Neurological research.

Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab

D. Horáková, M. Týblová, V. Mikulová, 2023, Frontiers in immunology.

Quality of life, health-related quality of life, and associated factors in Huntington’s disease: a systematic review

N. Chavannes, R. Moldovan, J. Roth, 2023, Journal of Neurology.

H53 Does the risperidone influence weight in huntington’s disease?

J. Roth, J. Klempír, P. Dušek, 2018, Clinical care and clinical services.

Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab

D. Horáková, M. Týblová, V. Mikulová, 2023, Frontiers in immunology.